The Food and Drugs Authority (FDA) has approved two (2) more COVID-19 vaccines for importation, distribution, and use in Ghana.
The two new vaccines are Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty) bringing the total number of approved COVID-19 vaccines for use in Ghana to five.
The FDA in a statement said it continues to use the Emergency Use Authorization (EUA) pathway, which is the accepted procedure for all national regulatory authorities globally, to ensure timely access to quality and safe medical products including vaccines during this pandemic.